T. Tian

Clinical and Pathological Characteristics of Young Female Breast Cancer

Chengshi Wang, T. Luo, X. Zhong, 2021 .

High expression levels of centromere protein A plus upregulation of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway affect chemotherapy response and prognosis in patients with breast cancer

Q. Lv, Yuting Zhou, J. Qiu, 2021, Oncology letters.

Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in a Chinese population.

T. Luo, X. Zhong, P. He, 2013, Asian Pacific journal of cancer prevention : APJCP.

Neoadjuvant pyrotinib plus trastuzumab and nab-paclitaxel for HER2-positive early or locally advanced breast cancer: an exploratory phase II trial.

Q. Lv, Xiaodong Wang, Jing Wang, 2022, Gland surgery.